US Patent 7550598 Kinase inhibitors
Patent 7550598 was granted and assigned to Takeda Pharmaceutical Company on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+146 characters)
Article
Patent abstract
Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound of the formula:
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07550598 Kinase inhibitors US Patent 7550598 Kinase inhibitors
Infobox
Patent Number
0755059800
Patent Number
755059800
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075505980
Date of Patent
June 23, 2009
0Patent Application Number
112084370
Date Filed
August 18, 2005
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075505980
Date of Patent
June 23, 2009
0Patent Application Number
112084370
Date Filed
August 18, 2005
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07550598 Kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07550598
Date of patent
June 23, 2009
Patent application number
11208437
Date Filed
August 18, 2005
Patent primary examiner
Find more entities like US Patent 7550598 Kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.